Thermo Fisher Plans $180 Million Viral Vector Manufacturing Plant
May 11 2020 - 9:05AM
Dow Jones News
By Colin Kellaher
Thermo Fisher Scientific Inc. on Monday said it will invest $180
million in a new commercial manufacturing site in Plainville,
Mass., to expand its capacity for viral vector development and
manufacturing services.
The Waltham, Mass., maker of analytical instruments and
equipment for research, analysis and diagnostics said the project
will more than double its commercial viral vector capacity to
support increasing demand for gene therapies and vaccines.
Thermo Fisher said the 290,000-square-foot plant, which it
expects to complete in 2022, will add more than 200 jobs.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 11, 2020 08:50 ET (12:50 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024
